LFn-p24 fusion vaccine (Walter Reed Army Institute of Research)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameLFn-p24 fusion vaccine (Walter Reed Army Institute of Research)

Drug Alias NameHIV immunotherapeutic (Walter Reed Army Institute of Research/AVANT)Therapore-HIVHIV immunotherapeutic (WRAIR/AVANT)Therapore-P24

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesWalter Reed Army Institute Of Research

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesWalter Reed Army Institute Of Research

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A